Article
Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma
2022-08-19
Abstract excerpt
<h4>Background: </h4> Today, individual prognosis in patients with adenocarcinoma of the esophagus (EAC) is based on post-surgical TNM staging and valid biomarkers are still not implemented. Integrin beta1 (ITGB1) is widely expressed in epithelial cells and promotes cell adhesion and growth. Its impact on tumor progression was described for different tumor entities before, data on its function as biomarker in EAC...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a486c452-4b1f-5ed2-b011-990c73373da2
- DOI
- 10.21203/rs.3.rs-1934344/v1
